乳腺癌分期:数字乳腺断层合成联合自动乳腺超声与磁共振成像的比较
该回顾性研究纳入73例组织学确诊的乳腺癌患者,比较术前DBT-ABVS与1.5 T MRI在乳腺癌分期中的诊断准确性。DBT-ABVS对全部癌症的诊断准确性为90.0%,MRI为93.8%,两者可比;但DBT-ABVS对附加病变的敏感度和阳性预测值低于MRI。ABVS在评估肿瘤大小方面与MRI的一致性高于DBT。作者认为DBT-ABVS诊断准确性可接受,可在MRI不可用或不可行时使用。
要点
- DBT-ABVS对全部癌症诊断准确性90.0%,MRI为93.8%,两者可比。
- DBT-ABVS对附加病变敏感度76.5%、阳性预测值78.8%,均低于MRI。
- ABVS评估肿瘤大小与MRI的一致性高于DBT。
核心结论
- DBT-ABVS诊断准确性低于MRI但可接受,作者认为在MRI不可用或不可行时可能可使用该策略。
研究设计与样本
- 回顾性纳入2015年7月至2016年7月期间73例组织学确诊乳腺癌患者,术前均行DBT、ABVS和1.5 T MRI;两名放射科医师共识阅片,比较DBT-ABVS与MRI两种独立阅读策略,以组织学或1年随访为标准参考。
诊断标准与关键数值
- DBT-ABVS对全部癌症诊断准确性90.0%(95%CI 84.3-94.2),MRI为93.8%(95%CI 88.8-97.0)。
- DBT-ABVS对附加病变敏感度76.5%(95%CI 58.8-89.3),MRI为91.7%(95%CI 84.6-96.1)。
- DBT-ABVS对附加病变阳性预测值78.8%(95%CI 61.0-91.0),MRI为93.4%(95%CI 86.9-97.3)。
- 共160个病变(108个恶性、52个良性);恶性病变单灶、多灶、多中心及双侧分别为53、15、4和1例。
临床应用与阅片要点
- 与MRI相比,ABVS+DBT漏诊6个病变,包括2个浸润性癌和1个与导管原位癌相关的广泛血管内侵犯。
- Bland-Altman分析显示ABVS评估肿瘤大小与MRI的一致性高于DBT。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate whether combined Digital breast tomosynthesis and Automated breast volume scanner (DBT-ABVS) are comparable to Magnetic resonance imaging (MRI) in staging breast cancer.
METHODS: We retrospectively included seventy-three patients with histologically proven breast cancer who underwent preoperative DBT, ABVS and 1.5 T MRI in the period July 2015-July 2016. Two radiologists in consensus recorded the number, site and Breast imaging-reporting and data system (BI-RADS) category of breast findings during two independent reading strategies, i.e. DBT-ABVS vs. MRI. Using histology or 1-year follow up as the standard of reference, we calculated the accuracy for cancer of both imaging strategies. Bland-Altman analysis was used to evaluate the agreement between MRI vs. DBT or ABVS in cancer size assessment.
RESULTS: Patients showed a total of 160 lesions (108 malignant and 52 benign). Malignant lesions were unifocal, multifocal, multicentric and biltateral in 53, 15, 4 and 1 cases, respectively. Diagnostic accuracy of DBT-ABVS vs. MRI was comparable for all cancers (90.0% [95%C.I. 84.3-94.2] vs. 93.8% [95%C.I. 88.8-97.0], respectively). DBT-ABVS showed lower sensitivity and positive predictive values for additional disease (76.5% [95%C.I. 58.8-89.3] vs. 91.7% [95%C.I. 84.6-96.1], and 78.8% [95%C.I. 61.0-91.0] vs 93.4% [95%C.I. 86.9-97.3], respectively). Compared to MRI, ABVS + DBT missed 6 lesions, including two invasive cancers and one extensive intravascular invasion associated to ductal carcinoma in situ. Bland-Altman analysis showed ABVS to agree with MRI at a higher extent than DBT in assessing cancer size.
CONCLUSIONS: Though less performing than MRI, DBT-ABVS showed acceptable diagnostic accuracy in staging breast cancer. This strategy might be used if MRI is unavailable or unfeasible.
引用
- Girometti R, Tomkova L, Cereser L, et al. Breast cancer staging: Combined digital breast tomosynthesis and automated breast ultrasound versus magnetic resonance imaging. Eur J Radiol. 2018. PMID: 30292265. doi:10.1016/j.ejrad.2018.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。